Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 30, Issue 6, 2003, Pages 1157-1163

  Okamoto, Toshihiro ^a   Saito, Seiji ^b   Yamanaka, Hisashi ^b   Tomatsu, Taisuke ^b   Kamatani, Naoyuki ^b   Ogiuchi, Hideki ^b   Uchiyama, Takehiko ^b   Yagi, Junji ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Co stimulatory Molecule; Rheumatoid Arthritis; T Lymphocytes

Indexed keywords

ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; H4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; LIGAND; LYMPHOKINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTHRITIS; ARTICLE; BLOOD LEVEL; CELL FRACTIONATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; MALE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, SURFACE; ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION; HUMANS; JOINTS; LIGANDS; LYMPHOKINES; MALE; MIDDLE AGED; SYNOVIAL FLUID;

EID: 0037643418     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 1990;322:1277-89.
2. Panayi GS, Lanchbury JS, Kingesley GH. The importance of the T cells in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992;35:729-35.
3. Kurosaka M, Ziff M. Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med 1983;158:1191-210.
4. Kohem CL, Brezinschek RI, Wisbey H, Tortorella C, Lipsky PE, Oppenheimer-Marks N. Enrichment of differentiated CD45BRdim, CD27-memory T cells in the peripheral blood, SF, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 1996;39:844-54.
5. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996;14:397-440.
6. Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW. Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum 1997;40:5-18.
7. Odeh M. New insights into the pathogenesis and treatment of rheumatoid arthritis. Clin Immunol Immunopathol 1997;83:103-16.
8. van Roon JA, Lafeber FP, Bijlsma JW. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis. Arthritis Rheum 2001;44:3-12.
9. Miossec P. Are T cells in rheumatoid synovium aggressors or bystanders? Curr Opin Rheumatol 2000;12:181-5.
10. Redoglia V, Dianzani U, Rojo JM, et al. Characterization of H4: a mouse T lymphocyte activation molecule functionally associated with the CD3/T cell receptor. Eur J Immunol 1996;26:2781-9.
11. Yagi J, Diazani U, Kato H, et al. Identification of a new type of invariant Vα14+ T cells and responsiveness to a superantigen, Yersinia pseudotuberculosis-derived mitogen. J Immunol 1999;163:3083-91.
12. Buonfiglio D, Bragardo M, Bonissoni S, et al. Characterization of a novel human surface molecule selectively expressed by mature thymocytes, activated T cells and subsets of T cell lymphomas. Eur J Immunol 1999;29:2863-74.
13. Lucia MB, Buonfiglio D, Bottarel F, et al. Expression of the novel T cell activation molecule hpH4 in HIV-infected patients: correlation with disease status. AIDS Res Hum Retroviruses 2000;16:549-57.
14. Hutloff A, Dittrich AM, Beier KC, et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 1999;397:263-6.
15. Buonfiglio D, Bragardo M, Redoglia V, et al. The T cell activation molecule H4 and the CD28-like molecule ICOS are identical. Eur J Immunol 2000;30:3463-7.
16. Yoshinaga SK, Whoriskey JS, Khare SD, et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999;402:827-32.
17. McAdam AJ, Chang TT, Lumelsky AE, al. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regultes differentiation of CD4+ T cells. J Immunol 2000;165:5035-40.
18. Kopf M, Coyle AJ, Schmitz N, et al. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J Exp Med 2000;192:53-61.
19. McAdam AJ, Greenwald RJ, Levin MA, et al. ICOS is critical for CD40-mediated antibody class switching. Nature 2001;409:102-5.
20. Arimura Y, Kato H, Dianzani U, et al. Co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T-helper cells and regulates their response. Int Immunol 2002;14:555-66.
21. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
22. Pinals RS, Baum J, Bland J, et al. Preliminary criteria for clinical remission in rheumatoid arthritis. Bull Rheum Dis 1982;32:7-10.
23. Altman RD, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
24. Akatsuka H, Imanishi K, Inada K, Yamashita H, Yoshida M, Uchiyama T. Production of tumour necrosis factors by human T cells stimulated by a superantigen, toxic shock syndrome toxin-1. Clin Exp Immunol 1994;96:422-6.
25. Uchiyama T, Kamagata Y, Yan XJ, et al. Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin. Clin Exp Immunol 1987;68:638-47.
26. Uchiyama T, Imanishi K, Saito S, et al. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules. Eur J Immunol 1989;19:1803-9.
27. Uchiyama T, Miyoshi-Akiyama T, Kato H, Fujimaki W, Imanishi K, Yan XJ. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J Immunol 1993;151:4407-13.
28. Uchiyama T, Saito S, Inoko H, et al. Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin. Infect Immun 1990;58:3877-82.
29. Kato H, Fujimaki W, Narimatu H, Yagi J, Imanishi K, Uchiyama T. Study of TCR Vββ usage in superantigen-reactive human T cells by the RT-PCR method. J Tokyo Womens Med Coll 1994;64:985-93.
30. Uchiyama T, Kamagata Y, Wakai M, Yoshioka M, Fujikawa H, Igarashi H. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin. Microbiol Immunol 1986;30:469-83.
31. Beacock-Sharp H, Young JL, Gaston JS. Analysis of T cell subsets present in the peripheral blood and SF of reactive arthritis patients. Ann Rheum Dis 1998;57:100-6.
32. Iannone F, Corrigall VM, Kingsley GH, Panayi GS. Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis. Eur J Immunol 1994; 24:2706-13.
33. Coyle AJ, Lehar S, Lloyd C, et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 2000;13:95-105.
34. Dong C, Juedes AE, Temann UA, et al. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature 2001;409:97-101.
35. Sporici RA, Beswick RL, von Allmen C, et al. ICOS ligand costimulation is required for T-cell encephalitogenicity. Clin Immunol 2001;100:277-88.
36. Ozkaynak E, Gao W, Shemmeri N, et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol 2001;2:591-6.
37. Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFa. Immunity 1999;11:423-32.
38. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.